candesartan cilexetil has been researched along with Fatigue in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Fatigue: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan cilexetil was well tolerated at all doses." | 6.69 | Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators. ( Arens, H; Bouzo, H; George, M; Münz, J; Pethig, H; Petr, P; Riegger, GA; Spacek, R; von Behren, V, 1999) |
| "Candesartan cilexetil was well tolerated at all doses." | 2.69 | Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators. ( Arens, H; Bouzo, H; George, M; Münz, J; Pethig, H; Petr, P; Riegger, GA; Spacek, R; von Behren, V, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riegger, GA | 1 |
| Bouzo, H | 1 |
| Petr, P | 1 |
| Münz, J | 1 |
| Spacek, R | 1 |
| Pethig, H | 1 |
| von Behren, V | 1 |
| George, M | 1 |
| Arens, H | 1 |
1 trial available for candesartan cilexetil and Fatigue
| Article | Year |
|---|---|
Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive A | 1999 |